Antimicrobials are critical in treating diseases, not only in humans but also in animals and plants. However, for various reasons, microorganisms can develop resistance to an antimicrobial. As a result of resistance, standard treatment becomes ineffective, and the microorganisms continue to survive and multiply, leading to transmission. Antimicrobial-resistant (AMR) microorganisms can move between humans, animals, plants, and even food and the environment.
As more organisms become resistant to antimicrobials, surveillance is essential to track their spread. However, as the organisms are able to spread across different sectors (e.g. from animal to food to human), surveillance should be conducted through a One Health approach. Open Evidence, together with PwC EU Services, the Instituto de Biomedicina de Sevilla (IBiS) and Università di Verona, will support EU efforts on this important topic. The project, under the guidance of DG SANTE and HaDEA, involves extensive desk research, the mapping of surveillance activities in EU/EEA Member States, and the development of case studies. The findings will be synthesised into concrete recommendations for Member States and propose solutions to overcome any challenge Member States may face in the development of national integrated systems for the surveillance of AMR and AMC.
This 10-month project supports the objectives of the Council Recommendation on stepping up EU actions to combat antimicrobial resistance in a One Health approach, particularly recommendation 5(e). Open Evidence remains committed to supporting European Institutions in the achievement of all its public health goals.